Economic burden of hepatitis C in Egypt: the future impact of highly effective therapies

E-ISSN： 1365-2036|42|6|696-706

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.42, Iss.6, 2015-09, pp. : 696-706

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of fixed-dose and multi-pill combination dyslipidemia therapies on medication adherence and the economic burden of sub-optimal adherence

By Balu Sanjeev Simko Robert J. Quimbo Ralph M. Cziraky Mark J.

Current Medical Research and Opinion, Vol. 25, Iss. 11, 2009-11 ,pp. : 2765-2775

Informa Healthcare

Access to resources Recommend Favorite

P065: Hepatitis B Burden in a growing world: assessing the impact of demography and the effect of vaccination on future generations

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 52-53

John Wiley & Sons Inc

Access to resources Recommend Favorite

The present and future disease burden of hepatitis C virus infections with today's treatment paradigm – volume 3

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S4, 2015-12 ,pp. : 21-41

John Wiley & Sons Inc

Access to resources Recommend Favorite

A glass half full: Implications of screening for hepatitis C virus in the era of highly effective antiviral therapy

HEPATOLOGY, Vol. 61, Iss. 5, 2015-05 ,pp. : 1455-1458

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of hepatitis C with 8 weeks of ledipasvir/sofosbuvir: Highly effective in a predominantly black male patient population

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 25, Iss. 2, 2018-02 ,pp. : 205-208

John Wiley & Sons Inc

Access to resources Recommend Favorite